Organ-Space Surgical Site Infection, Rectal Cancer
Conditions
Keywords
Surgical Site Infection, Rectal cancer, Rectal Surgery, Databases concordance
Brief summary
The Catalan Cancer Plan (CCP) undertakes periodic audits of cancer treatment outcomes, including organ/space surgical site infections (O/S-SSI) rates, while the Catalan Healthcare-associated Infections Surveillance Programme (VINCat) carries out standardized prospective surveillance of surgical site infections (SSIs) in colorectal surgery. This cohort study aimed to assess the concordance between these two monitoring systems for O/S-SSI following primary rectal cancer surgery.
Detailed description
The healthcare system in Catalonia (Spain) monitors and reports SSI in cancer patients through two principal mechanisms. First of all, the Catalan Cancer Plan (CCP) is a Health Department structure that aims to improve the quality of care for cancer patients by means of periodic auditing of outcomes with real-world data and feedback to professionals. One indicator included in these compulsory audits is the occurrence of O/S-SSI. On the other hand, the Catalan Healthcare-associated Infections Surveillance Programme (VINCat) is a nationwide network for hospital-acquired infections (HAI) which conducts surveillance in colorectal surgery. The two systems thus operate with an important difference: the CCP audits are mandatory and cover all cancer surgeries performed in centres funded through the public healthcare system, while VINCat is a voluntary registry programme among participating centres. The selected cases and methods used to detect O/S-SSI may therefore vary substantially between auditing systems. This retrospective population-based cohort study aims to assess the concordance between clinical audits of the CCP and the VINCat registry as a preliminary step to studies correlating local recurrence after rectal cancer surgery and O/S-SSI.
Interventions
Concordance between the two registers was analysed using Cohen´s Kappa.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients \> 18 years old * Eligible patients with tumour ≤ 13 cm from anal verge, as measured by Magnetic Resonance Imaging * Primary adenocarcinoma * Oncological resection with curative intent * Cancer stages: I-II-III
Exclusion criteria
* Transanal local resection * Emergency colorectal surgeries * Presence of metastases found in the diagnostic process or during the surgical procedure * Recurrence of the disease treated before the study period * Non-resectable tumour or palliative surgery * Patients operated in private centres
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of Organ-space surgical site infection | 30 days | As described by the Centers for Disease Control: an infection occurring within 30 days of the surgical procedure and involves any part of the body deeper than the fascial/muscle layers that is opened or manipulated during surgery. In addition, the patient must present at least one of the following associated events: a purulent drainage from a drain placed into the organ/space |
Countries
Spain